Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Invesco Ltd (NYSE: IVZ) closed at $23.61 in the last session, up 2.25% from day before closing price of $23.09. In other words, the price has increased by $2.25 from its previous closing price. On the day, 4.31 million shares were traded. IVZ stock price reached its highest trading level at $23.83 during the session, while it also had its lowest trading level at $23.1071.
Ratios:
We take a closer look at IVZ’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.06 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.75. For the most recent quarter (mrq), Quick Ratio is recorded 1.04 and its Current Ratio is at 1.04. In the meantime, Its Debt-to-Equity ratio is 0.62 whereas as Long-Term Debt/Eq ratio is at 0.62.
On July 11, 2025, Wells Fargo Upgraded its rating to Equal Weight which previously was Underweight but kept the price unchanged to $18.
TD Cowen Downgraded its Buy to Hold on April 09, 2025, whereas the target price for the stock was revised from $22 to $13.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 10 ’25 when Butcher Stephanie sold 103,192 shares for $22.12 per share. The transaction valued at 2,282,710 led to the insider holds 29,855 shares of the business. Butcher Stephanie bought 103,192 shares of IVZ for $2,282,708 on Sep 10 ’25.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IVZ now has a Market Capitalization of 10529205248 and an Enterprise Value of 15586704384. As of this moment, Invesco’s Price-to-Earnings (P/E) ratio for their current fiscal year is 25.36, and their Forward P/E ratio for the next fiscal year is 10.10. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.63. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.71 while its Price-to-Book (P/B) ratio in mrq is 0.97. Its current Enterprise Value per Revenue stands at 2.533 whereas that against EBITDA is 12.739.
Stock Price History:
The Beta on a monthly basis for IVZ is 1.69, which has changed by 0.33089066 over the last 52 weeks, in comparison to a change of 0.16766965 over the same period for the S&P500. Over the past 52 weeks, IVZ has reached a high of $23.20, while it has fallen to a 52-week low of $11.60. The 50-Day Moving Average of the stock is 8.36%, while the 200-Day Moving Average is calculated to be 34.91%.
Shares Statistics:
According to the various share statistics, IVZ traded on average about 5.70M shares per day over the past 3-months and 4900250 shares per day over the past 10 days. A total of 445.96M shares are outstanding, with a floating share count of 442.57M. Insiders hold about 0.76% of the company’s shares, while institutions hold 92.37% stake in the company. Shares short for IVZ as of 1757894400 were 13501911 with a Short Ratio of 2.37, compared to 1755216000 on 14134648. Therefore, it implies a Short% of Shares Outstanding of 13501911 and a Short% of Float of 5.2800003.
Dividends & Splits
The forward annual dividend rate for IVZ is 0.83, which was 0.83 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.035946295. The stock’s 5-year Average Dividend Yield is 4.24. The current Payout Ratio is 69.23% for IVZ, which recently paid a dividend on 2025-08-14 with an ex-dividend date of 2025-08-14. Stock splits for the company last occurred on 2000-11-08 when the company split stock in a 25:10 ratio.
Earnings Estimates
Current recommendations for the stock of the company come from 13.0 analysts. The consensus estimate for the next quarter is $0.55, with high estimates of $0.61 and low estimates of $0.48.
Analysts are recommending an EPS of between $1.86 and $1.71 for the fiscal current year, implying an average EPS of $1.79. EPS for the following year is $2.33, with 14.0 analysts recommending between $2.6 and $2.04.
Revenue Estimates
According to 6 analysts,. The current quarter’s revenue is expected to be $1.17B. It ranges from a high estimate of $1.2B to a low estimate of $1.16B. As of. The current estimate, Invesco Ltd’s year-ago sales were $1.1BFor the next quarter, 6 analysts are estimating revenue of $1.23B. There is a high estimate of $1.25B for the next quarter, whereas the lowest estimate is $1.2B.
A total of 7 analysts have provided revenue estimates for IVZ’s current fiscal year. The highest revenue estimate was $4.66B, while the lowest revenue estimate was $4.58B, resulting in an average revenue estimate of $4.62B. In the same quarter a year ago, actual revenue was $4.4BBased on 7 analysts’ estimates, the company’s revenue will be $5.11B in the next fiscal year. The high estimate is $5.25B and the low estimate is $4.94B.
